Thursday, March 23, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Steering Committee Chair
Professor of Endocrinology and Metabolism
School of Medicine
University of Pisa
Chief of the Section of Diabetes
University Hospital of Pisa
Pisa, Italy
Deputy Head of the Department of Endocrinology
Diabetology and Metabolism
Antwerp University Hospital
Antwerp, Belgium
Professor of Diabetes Medicine
University of Leicester and
University Hospitals of Leicester NHS Trust
Leicester, United Kingdom
Professor
Internal Medicine and Endocrinology
University Mainz
Chairman of the Executive Board
Clinical Research Services
Mannheim, Germany
Professor of Medicine
Head of the Division of Diabetology and GI Endocrinology
St Josef-Hospital of the Ruhr-University of Bochum
Bochum, Germany
Professor
Steno Diabetes Center Copenhagen
Gentofte Hospital
University of Copenhagen
Copenhagen, Denmark
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Applied Therapeutics; AstraZeneca; Boehringer Ingelheim; Eli Lilly and Co; Merck & Co.; Novartis Pharmaceuticals; Novo Nordisk; Sanofi
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Boehringer Ingelheim; Eli Lilly and Company; Merck & Co.; Novartis Pharmaceuticals; Novo Nordisk; Sanofi; Takeda Pharmaceuticals
Received grants for clinical research from: AstraZeneca; Boehringer Ingelheim
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott; AstraZeneca; Boehringer Ingelheim; A. Menarini Diagnostics; Eli Lilly and Company; Medtronic; Novo Nordisk; Roche
Served as a speaker or a member of a speakers bureau for: Eli Lilly and Company; Novo Nordisk
Received grants for clinical research from: AstraZeneca; Eli Lilly and Company; Medtronic; Novo Nordisk
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Boehringer Ingelheim; Lexicon; Eli Lilly and Company; Novo Nordisk; Sanofi
Served as a speaker or a member of a speakers bureau for: Actoverco Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; CCL Pharmaceuticals; Eli Lilly and Company; Napp Pharmaceuticals; Novo Nordisk; Pfizer; Sanofi
Received grants for clinical research from: AstraZeneca; Novo Nordisk; Boehringer Ingelheim; Janssen; Sanofi
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Bayer; Cipla; Eli Lilly; Eyesense; Fortbildungskolleg; Novo Nordisk; Pfizer; Sanofi; Bayer; Roche
Served as a speaker or a member of a speakers bureau for: Abbott; AstraZeneca; Boehringer Ingelheim; Berlin Chemie; Cipla; Eli Lilly and Company; Fortbildungskolleg; Merck Sharp & Dohme; Novartis; Novo Nordisk; Sanofi
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Bristol Myers Squibb; Boehringer Ingelheim; Eli Lilly and Company; Merck Sharp & Dohme; Novo Nordisk; Sanofi-Aventis
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Bristol Myers Squibb; Boehringer Ingelheim; Eli Lilly and Company; Merck Sharp & Dohme; Novo Nordisk; Sanofi-Aventis
Received grants for clinical research from: Boehringer Ingelheim; Merck Sharp & Dohme; Novo Nordisk; Sanofi-Aventis
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Bristol Myers Squibb; Boehringer Ingelheim; Gilead; Eli Lilly and Company; Merck Sharp & Dohme; Mundipharma; Novo Nordisk; Sun Pharma
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Bristol Myers Squibb; Boehringer Ingelheim; Gilead; Eli Lilly and Company; Merck Sharp & Dohme; Mundipharma; Novo Nordisk; Sun Pharma
Received grants for clinical research from: Boehringer Ingelheim; Eli Lilly and Company; Novo Nordisk
